1-4 of 4
Vanessa Roldán
Close
Sort by
Journal Articles

Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy

Brief Report
Virginia Pérez-Andreu, Vanessa Roldán, Ana Isabel Antón, Nuria García-Barberá, Javier Corral, Vicente Vicente, Rocio González-Conejero
Journal: Blood
Blood (2009) 113 (20): 4977–4979.
https://doi.org/10.1182/blood-2008-09-176222
Published: 2009
Journal Articles

Real-World Clinical Experience with Long-Term Miglustat Therapy in Type 1 Gaucher Disease: The ZAGAL Project

Pilar Giraldo, MD, PhD, Pilar Alfonso, MAngeles Fernandez-Galan, Guillermo Martín-Nuñez, Abelardo Barez, MD, Rafael Franco, Dora Alonso, Antonio Acedo, Alejandro Martin, Elvira Martinez-Estefano, Vanessa Roldan, Sol Serrano, Paz Latre, Miguel Pocovi
Journal: Blood
Blood (2008) 112 (11): 4638.
https://doi.org/10.1182/blood.V112.11.4638.4638
Published: 2008
Journal Articles

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis

Clinical Trials & Observations
Javier Corral, David Hernandez-Espinosa, Jose Manual Soria, Rocio Gonzalez-Conejero, Adriana Ordonez, Jose Ramon Gonzalez-Porras, Elena Perez-Ceballos, Ramon Lecumberri, Ignacio Sanchez, Vanessa Roldan, Jose Mateo, Antonia Minano, Marcos Gonzalez, Ignacio Alberca, Jordi Fontcuberta, Vicente Vicente
Journal: Blood
Blood (2007) 109 (10): 4258–4263.
https://doi.org/10.1182/blood-2006-08-040774
Published: 2007
Journal Articles

Short-Term Effect of Oral Treatment with Miglustat in Type 1 Gaucher Disease.

Pilar Giraldo, MD, PhD, Dora Alonso, MDPhD, M. Acedo, MD, Rafael Franco, MD, Alberto Barez, MD, Alejandro Corrales, MDPhD, D. Serrano, MD, Vanessa Roldan, MD, Paz Latre, MD, Pilar Alfonso, MDPhD, Miguel Pocovi, MDPhD
Journal: Blood
Blood (2005) 106 (11): 2235.
https://doi.org/10.1182/blood.V106.11.2235.2235
Published: 2005